| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Fundraising > Fundraising Mailing Lists: How List Brokers Can Help |
|
Main Subject - Fundraising Mailing Lists: How List Brokers Can Help
Last time I checked, there were 25,000 response lists and 50,000 compiled lists currently on the market. Among all of these lists, you'll find hundreds t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hat work for fundraising appeals. Actually, you likely won't find them. Locating the best names for your mailing is complicated and best left to an exper ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ienced list broker. A list broker is a specialist who researches and recommends lists for you, and manages all the paperwork and other details lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. of renting the list. An experienced list broker:
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe li>helps you create a matrix for testing your mailing against other lists d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ds other media (such as email) to consider testing ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ates, gift income and other results A Typical List Rental Transaction
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ist broker that specializes in the non-profit sector nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically describe your ideal donor (such as "female, 55 years old, married, owns home, $150,000 household income, cares about animal welfare, lives in the United and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ States and responds to direct mail fundraising appeals from animal rights organizations") ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi il package that you are going to mail to the list, and the list broker forwards it to the list owner ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a kage
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod n you will mail your piece cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin >The list broker prepares your list and sends it to your lettershop or service bureau tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen so you can track the results of this mailing back to this list t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel you receive, adding the names to your database (they are yours to keep), and flagging each new donor record to note the package and list used to acquire ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the donor * A select is a process that the list broker conducts on your behalf to choose only some names from the entire list. You might ask t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products he broker to select names from a particular zip code, for example, and only rent you those
names. Mailing list brokers know the industry. The firms th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ey work for have researched and tested thousands of lists. So working with a qualified mailing list broker is vital. © 2006 Sharpe Copy Inc. You elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip may reprint this article online and in print provided the links remain live and the content remains unaltered (including the "About the Author" message) tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Get Along with Your Boss
|